Invivyd IVVD
NASDAQ IVVD
$0.87 +0.01 (+1.75%)
As of: Sep 30, 2026 · 3:59 PM EDT

Invivyd (IVVD) Net Margin (2024 - 2026)

Updated

Invivyd (IVVD) recorded Net Margin of -310.77% in Q2 2026, down 186.38 percentage points from -124.38% a year earlier.

Analysis

Invivyd (IVVD) Net Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Invivyd's Net Margin came in at -142.90% as of Jun 30, 2026, up 95.43 percentage points year-over-year; for FY2025, it was -98.27%, up 571.15 percentage points from FY2024.

  • Across earlier years, Net Margin came in at -669.42% in FY2024.
  • The Q2 2026 figure is the lowest quarterly Net Margin since Q3 2024.
  • On a year-over-year basis, Net Margin rose in three of the last four quarters, with an average year-over-year change of +604.63 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 21.86%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 21.27%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -8.04%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 22.61%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.81%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 23.62%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 32.99%
10 Invivyd 250.54 Mn -256.10 Mn 13.01 Mn -310.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -310.77%
Dec 31, 2025 -64.40%
Sep 30, 2025 -79.75%
Jun 30, 2025 -124.38%
Mar 31, 2025 -144.10%
Dec 31, 2024 -133.45%
Sep 30, 2024 -653.11%
Jun 30, 2024 -2,086.88%
API Access

Invivyd Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY